| Title： | Chinese expert consensus recommendations for management of thyroid diseases in female patients with early breast cancer (2024 edition) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians specializing in breast diseases in China |
| Evidence classification method： | GRADE分级系统并结合国内临床研究和专家临床经验 |
| Development unit： | The Society of Clinical Cancer Research Administration of China Anti-Cancer Association, Chongqing Federation of Clinical Medical Research, the Society of Onco-endocrinology of Chongqing Anti-Cancer Association |
| Registration time: | 2024-05-07 |
| Registration number： | PREPARE-2024CN633 |
| Purpose of the guideline: | The coexistence of thyroid nodules in breast cancer patients is widely observed, impacting the treatment and prognosis of breast cancer patients. In long-term survival cases of early-stage breast cancer, there is a notable high incidence of accompanying thyroid nodules, a trend that has gained increasing attention in recent years. Currently, there is a lack of consensus or guidelines regarding the diagnosis and treatment of thyroid nodules in breast cancer patients.Based on the guideline / expert consensus and the clinical experience of multiple medical centers, the Society of Breast Cancer Integration and Rehabilitation of China Anti-Cancer Association, in collaboration with the Chongqing Federation of Clinical Medical Research， Committee of Thyroid Disease of Chongqing Society of Integrated Traditional Chinese and Western Medicine, and the Society of Onco-endocrinology of Chongqing Anti-Cancer Association, has organized relevant experts to extensively discuss and formulate the "Chinese expert consensus recommendations for management of thyroid nodules in breast cancer women (2024 edition)", aiming to standardize the management of thyroid nodules in breast cancer women. |
Latest registration
